Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Replimune Group, Inc. | tm2034385d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Replimune Group, Inc. | tm2034385d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Replimune Group, Inc. | tm2034385d1_ex31-1.htm |
| 10-Q - FORM 10-Q - Replimune Group, Inc. | tm2034385-1_10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Replimune Group, Inc. (the “Company”) for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Philip Astley-Sparke, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 5, 2020 | By: | /s/ Philip Astley-Sparke |
| Philip Astley-Sparke | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |